Adherence in allergen immunotherapy: Current situation and future implications

Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Gehrt, Francesca, Xu, Qingqing, Baiardini, Ilaria, Canonica, Giorgio Walter, Pfaar, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707370/
https://www.ncbi.nlm.nih.gov/pubmed/36457724
http://dx.doi.org/10.5414/ALX02318E
_version_ 1784840701247225856
author Gehrt, Francesca
Xu, Qingqing
Baiardini, Ilaria
Canonica, Giorgio Walter
Pfaar, Oliver
author_facet Gehrt, Francesca
Xu, Qingqing
Baiardini, Ilaria
Canonica, Giorgio Walter
Pfaar, Oliver
author_sort Gehrt, Francesca
collection PubMed
description Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatment adherence in AIT and to provide possible solutions for improving adherence.
format Online
Article
Text
id pubmed-9707370
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dustri-Verlag Dr. Karl Feistle
record_format MEDLINE/PubMed
spelling pubmed-97073702022-11-30 Adherence in allergen immunotherapy: Current situation and future implications Gehrt, Francesca Xu, Qingqing Baiardini, Ilaria Canonica, Giorgio Walter Pfaar, Oliver Allergol Select Review Article Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatment adherence in AIT and to provide possible solutions for improving adherence. Dustri-Verlag Dr. Karl Feistle 2022-11-21 /pmc/articles/PMC9707370/ /pubmed/36457724 http://dx.doi.org/10.5414/ALX02318E Text en © Dustri-Verlag Dr. K. Feistle https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Gehrt, Francesca
Xu, Qingqing
Baiardini, Ilaria
Canonica, Giorgio Walter
Pfaar, Oliver
Adherence in allergen immunotherapy: Current situation and future implications
title Adherence in allergen immunotherapy: Current situation and future implications
title_full Adherence in allergen immunotherapy: Current situation and future implications
title_fullStr Adherence in allergen immunotherapy: Current situation and future implications
title_full_unstemmed Adherence in allergen immunotherapy: Current situation and future implications
title_short Adherence in allergen immunotherapy: Current situation and future implications
title_sort adherence in allergen immunotherapy: current situation and future implications
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707370/
https://www.ncbi.nlm.nih.gov/pubmed/36457724
http://dx.doi.org/10.5414/ALX02318E
work_keys_str_mv AT gehrtfrancesca adherenceinallergenimmunotherapycurrentsituationandfutureimplications
AT xuqingqing adherenceinallergenimmunotherapycurrentsituationandfutureimplications
AT baiardiniilaria adherenceinallergenimmunotherapycurrentsituationandfutureimplications
AT canonicagiorgiowalter adherenceinallergenimmunotherapycurrentsituationandfutureimplications
AT pfaaroliver adherenceinallergenimmunotherapycurrentsituationandfutureimplications

Ejemplares similares